Accéder au contenu
Merck
  • Design, synthesis, and SAR of 2-dialkylamino-4-arylpyrimidines as potent and selective corticotropin-releasing factor(1) (CRF(1)) receptor antagonists.

Design, synthesis, and SAR of 2-dialkylamino-4-arylpyrimidines as potent and selective corticotropin-releasing factor(1) (CRF(1)) receptor antagonists.

Bioorganic & medicinal chemistry letters (2004-04-15)
Charles Q Huang, Dimitri E Grigoriadis, Zhengyu Liu, James R McCarthy, John Ramphal, Thomas Webb, Jeffrey P Whitten, Michael Y Xie, Chen Chen
RÉSUMÉ

A series of 2-dialkylamino-4-phenylpyrimidines (7) was designed and synthesized as CRF(1) antagonists. SAR studies of this series resulted in the discovery of potent and selective antagonists 7b and 7n bearing a 4-(2,4,6-trisubstituted-phenyl) ring and a bulky 2-(N-bis(cyclopropane)methyl-N-propyl)amino group.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
2,4-Dichloropyrimidine, 98%